The COVID-19 pandemic has significantly impacted the Japanese large-joint reconstructive implant market, limiting hip and knee replacement procedures and unit sales. Following the impact of the…
Despite the impact of the ongoing COVID-19 pandemic, the Japanese urological device market will grow steadily through 2029, largely due to the growing elderly population. However, the market…
Following the initial impact of the COVID-19 pandemic, the Japanese market for TEO devices will expand at a modest rate, driven by the steady growth of Japan's aging population. However,…
The COVID-19 pandemic will have a significant impact on the Japanese laparoscopic device market. Once the market stabilizes, however, it will expand moderately through 2029, driven by an expanding…
The Japanese heart valve device market is large and expanding, with growth being driven primarily by the rapid adoption of THV devices and an aging population in this country. Additionally, as…
The Japanese gynecological device market will grow through 2029 due to the developing use of office-based procedures and continued marketing efforts and technological improvements made to…
While the COVID-19 pandemic will negatively impact the Japanese market for aortic repair devices in the short term, the market for aortic repair devices will expand at a modest rate, driven…
Procedure deferrals due to the COVID-19 pandemic severely impacted the Japanese GI endoscopy device market, and the elective nature of many postponed procedures will hinder the pace of recovery to…
While the COVID-19 pandemic will have a negative, albeit relatively limited impact on Japanese interventional oncology device market in the short term, the market will grow moderately, driven by an…
Although the COVID-19 global pandemic has negatively impacted the Japanese EP mapping and ablation device market, the market is anticipated to recover over the near term, and subsequently resume…
The COVID-19 pandemic has had a significant impact on ENT procedure volumes. However, as the COVID-19 situation stabilizes, rising FESS procedure volumes and increasing adoption of innovative and…
While the COVID-19 pandemic will have negative, albeit relatively limited, impact on the Japanese neurovascular device market in the short term, the market will grow modestly through 2030, driven…
Although an aging population and the growing prevalence of complex lesions requiring niche devices, such as intravascular imaging catheters and CTO devices will support the Japanese IC device…
The continuing emergence of data supporting the safety of paclitaxel-coated devices will drive growing adoption of premium-priced DES and DCBs, supporting modest growth overall in the Japanese PV…
Although it will be impacted in the short term by the COVID-19 pandemic, the biosurgical agent market in Japan will grow at a moderate rate through 2029, driven by rising surgical procedure…